We transcribed and analyzed this morning’s Moberg Pharma (MOB.ST) conference call negative update on the MOB-015 nail fungus  trial results that sent the stock, as well as Canadian licensing partner (for nail fungus product) and GeoInvesting-covered stock, Cipher Pharmaceuticals (OTC:CPHRF) […]